"RADA-PHARMA" Ltd. (Russia) is developing innovative pharmaceuticals for the photodynamic therapy (PDT) of malignant and non-malignant neoplastic formations, microorganisms and pathologically altered tissues based on local phototoxic effect produced by a drug upon its interaction with light.
Fig. 1. Pharmaceuticals: Radachlorin drug substance and 2 final products
